A new study published in the journal of BMC Surgery showed that robotic surgery for rectal cancer exhibits oncological and ...

Artificial intelligence (AI) is transforming healthcare across multiple fields, and prostate cancer (PCa)  is no exception. A ...

The surge in early-onset colorectal cancer has prompted urgent campaigns to educate the public and health care ...

A stunning clinical trial has delivered results that doctors rarely see. Every single patient in the study saw their rectal ...

A personal trainer who followed a clean diet was diagnosed with colon cancer after her rectal bleeding and bloating were ...

National guidelines on prostate cancer screening with the PSA test are set by the U.S. Preventive Services Task Force (USPSTF ...

Despite a poor prognosis and resistance to chemotherapy, new targeted therapies based on genetic mutations are improving outcomes for patients with biliary tract cancer.

The Prognostic Nutritional Index (PNI) and systemic oxidative stress (SOS) score are independently associated with poorer prognosis of low-risk myelodysplastic syndrome (MDS), according to a study ...

Total neoadjuvant therapy demonstrates consistent real-world efficacy across regimens in patients with locally advanced rectal cancer, a study finds.

For patients with Stage III or IV colon and rectal cancer, especially those who are non-responsive to conventional therapies, immunotherapy offers new hope for long-term survival.